
RedHill Biopharma Announces Increase in Net Revenue, Prescriptions and Gross Profit for Q3 2021, Accelerates COVID-19 Pill Programs in Light of Potential Against Omicron
[ad_1]Dror Ben-Asher, CEO of RedHill, commented: âOur business in the United States continues to drive…